Resultats de la cerca - Nilofer S. Azad

Refinar resultats
  1. 1
    Immune checkpoint inhibitor therapy in biliary tract cancer (cholangiocarcinoma)

    Immune checkpoint inhibitor therapy in biliary tract cancer (cholangiocarcinoma) per Christopher Jakubowski, Nilofer S. Azad

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future

    Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future per Eric S. Christenson, Elizabeth M. Jaffee, Nilofer S. Azad

    Publicat 2020
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    The future of epigenetic therapy in solid tumours—lessons from the past

    The future of epigenetic therapy in solid tumours—lessons from the past per Nilofer S. Azad, Cynthia A. Zahnow, Charles M. Rudin, Stephen B. Baylin

    Publicat 2013
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Colorectal Cancer in the Young: Epidemiology, Prevention, Management

    Colorectal Cancer in the Young: Epidemiology, Prevention, Management per Rebecca L. Siegel, Christopher Jakubowski, Stacey A. Fedewa, Anjee Davis, Nilofer S. Azad

    Publicat 2020
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  5. 5
    Keratoacanthomas associated with sorafenib therapy

    Keratoacanthomas associated with sorafenib therapy per Heidi H. Kong, Edward W. Cowen, Nilofer S. Azad, William L. Dahut, Martin Gutierrez, Maria L. Turner

    Publicat 2006
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  6. 6
    Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease

    Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease per Michael Boyiadzis, John M. Kirkwood, John L. Marshall, Colin C. Pritchard, Nilofer S. Azad, James L. Gulley

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    Current Surgical Management Strategies for Colorectal Cancer Liver Metastases

    Current Surgical Management Strategies for Colorectal Cancer Liver Metastases per Gabriel D. Ivey, Fabian M. Johnston, Nilofer S. Azad, Eric S. Christenson, Kelly J. Lafaro, Christopher R. Shubert

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  8. 8
    Mutational profiling of colorectal cancers with microsatellite instability

    Mutational profiling of colorectal cancers with microsatellite instability per Elaine I. Lin, Li‐Hui Tseng, Christopher D. Gocke, Stacy Reil, Dung T. Le, Nilofer S. Azad, James R. Eshleman

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Single-Center Phase II Trial of Transarterial Chemoembolization With Drug-Eluting Beads for Patients With Unresectable Hepatocellular Carcinoma

    Single-Center Phase II Trial of Transarterial Chemoembolization With Drug-Eluting Beads for Patients With Unresectable Hepatocellular Carcinoma per Diane K. Reyes, Josephina A. Vossen, Ihab R. Kamel, Nilofer S. Azad, T. Wahlin, Michael Torbenson, Michael A. Choti, Jean-François H. Geschwind

    Publicat 2009
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Tumor Mutational Burden, Toxicity, and Response of Immune Checkpoint Inhibitors Targeting PD(L)1, CTLA-4, and Combination: A Meta-regression Analysis

    Tumor Mutational Burden, Toxicity, and Response of Immune Checkpoint Inhibitors Targeting PD(L)1, CTLA-4, and Combination: A Meta-regression Analysis per Arsen Osipov, Su Jin Lim, Aleksandra Popović, Nilofer S. Azad, Daniel A. Laheru, Lei Zheng, Elizabeth M. Jaffee, Hao Wang, Mark Yarchoan

    Publicat 2020
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  11. 11
    A randomized pilot trial of a telephone‐based couples intervention for physical intimacy and sexual concerns in colorectal cancer

    A randomized pilot trial of a telephone‐based couples intervention for physical intimacy and sexual concerns in colorectal cancer per Jennifer Barsky Reese, Laura S. Porter, Katelyn R. Regan, Francis J. Keefe, Nilofer S. Azad, Luis A. Díaz, Joseph M. Herman, Jennifer A. Haythornthwaite

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models

    Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models per Chaoxin Hu, Tikva Dadon, Venugopal Chenna, Shinichi Yabuuchi, Rajat Bannerji, Robert Booher, Peter R. Strack, Nilofer S. Azad, Barry D. Nelkin, Anirban Maitra

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    <i>GPX3</i> promoter methylation predicts platinum sensitivity in colorectal cancer

    <i>GPX3</i> promoter methylation predicts platinum sensitivity in colorectal cancer per Lorraine Pelosof, Sashidhar R. Yerram, Todd D. Armstrong, Nina J. Chu, Ludmila Danilova, Breann Yanagisawa, Manuel Hidalgo, Nilofer S. Azad, James G. Herman

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity

    Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity per Jang‐Ming Lee, Gisele Sarosy, Christina M. Annunziata, Nilofer S. Azad, Lori M. Minasian, Herb Kotz, James E. Squires, Nicole Houston, Elise C. Kohn

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Gastrointestinal ostomies and sexual outcomes: a comparison of colorectal cancer patients by ostomy status

    Gastrointestinal ostomies and sexual outcomes: a comparison of colorectal cancer patients by ostomy status per Jennifer Barsky Reese, Patrick H. Finan, Jennifer A. Haythornthwaite, Maura Kadan, Katelyn R. Regan, Joseph M. Herman, J. Efron, Luis A. Díaz, Nilofer S. Azad

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers

    Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers per Lisa Haley, Li‐Hui Tseng, Gang Zheng, Jonathan C. Dudley, Derek A. Anderson, Nilofer S. Azad, Christopher D. Gocke, James R. Eshleman, Ming‐Tseh Lin

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases

    Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases per Georgios Karagkounis, Michael Torbenson, Hubert Darius Daniel, Nilofer S. Azad, Luis A. Díaz, Ross C. Donehower, Kenzo Hirose, Nita Ahuja, Timothy M. Pawlik, Michael A. Choti

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma

    The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma per Rachna T. Shroff, Mark Yarchoan, Ashley O’Connor, Denise Gallagher, Marianna Zahurak, Gary L. Rosner, Chimela Ohaji, Susan Sartorius‐Mergenthaler, Vivek Subbiah, Ralph Zinner, Nilofer S. Azad

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours

    Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours per Devalingam Mahalingam, George Wilding, Samuel R. Denmeade, J. Sarantopoulas, David Cosgrove, Jeremy Cetnar, Nilofer S. Azad, Justine Y. Bruce, Michael R. Kurman, Victoria Allgood, Michael A. Carducci

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017

    Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017 per Milind Javle, Sunyoung Lee, Nilofer S. Azad, Mitesh J. Borad, Robin Kate Kelley, Smitha Sivaraman, Anna Teschemaker, Ishveen Chopra, Nora A. Janjan, Shreekant Parasuraman, Tanios Bekaii‐Saab

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: